Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Caredx Inc.
Headquarters: Brisbane, CA, United States of America
Website: http://www.caredxinc.com
Year Founded: 2000
Status: Public
Industry Sector: HealthTechnology
CEO: John W. Hanna, MBA
Number Of Employees: 650
Enterprise Value: $979,959,832
PE Ratio: 17.66
Exchange/Ticker 1: NASDAQ:CDNA
Exchange/Ticker 2: N/A
Latest Market Cap: $1,017,065,280
BioCentury | May 9, 2024
Management Tracks
Reginald Seeto at the helm of Scipher
Plus: New heads of commercial and strategy at AdvanCell, and an update from Vivodyne
BioCentury | Apr 23, 2024
Management Tracks
Bill Meury named CEO of Anthos
Plus: Fujimoto to lead Takeda-Astellas-Sumitomo’s JV, and updates from Sofinnova Partners, SystImmune, Amarna and Cytonus
BioCentury | Oct 13, 2022
Management Tracks
Maag becomes CEO at Kyverna
Plus Bernstein to head R&D at Maze, and updates from Visiox, Araris, Quest and Biohaven
BioCentury | Aug 2, 2022
Management Tracks
Mackison named CEO at Vico
Plus Arvinas hires Northcott as CCO, Manion joins Aclaris and updates from AnHeart, Gracell, Find and more
BioCentury | Jun 2, 2022
Management Tracks
Anderson to lead Pfizer’s vaccine R&D
Plus CFO Luca Scavo resigns from Evelo, Passage Bio’s CEO steps down, and updates from MindMaze, Black Diamond and more
BioCentury | Nov 3, 2021
Management Tracks
O’Shaughnessy named acting chief scientist at FDA
Woollett joins Samsung Bioepis, Acadia, Aadi, Passage Bio and more
BioCentury | Jul 21, 2021
Management Tracks
Passage Bio builds out C-suite
Plus: Rome, Adagio, Iveric, Renovacor and more
BioCentury | Mar 17, 2021
Management Tracks
High-profile departures at Sage, bluebird as Cloonan, Davidson depart; plus CBC Group, Turning Point, Agilent, Intercept, Centessa, Beam and more
Mike Cloonan will depart Sage Therapeutics Inc. (NASDAQ:SAGE) as COO May 3 to pursue a CEO post in biopharma. The news comes after Barry Greene took Sage’s top spot in December. The
Items per page:
1 - 10 of 36